enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: SCHEDULE 13G
Filing Date: 17 Feb 2026Report Date:
Accepted: 17 Feb 2026 06:00 p.m.
Accession Number: 0001172661-26-001032
File Number: 005-94211
Film Number: 26640016